ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,217.03
-0.82%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) 뉴스

AZN AstraZeneca PLC

75.17
0.14 (0.19%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
AstraZeneca PLC AZN 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.14 0.19% 75.17 08:45:21
개장가 저가 고가 종가 전일 종가
75.00 74.59 75.49 75.17 75.03
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202421:00PRNUSAbelZeta Announces Abstract for C-CAR031 Accepted for..
25/04/202420:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
25/04/202420:52IHMARKETNEWSSouthwest Shares Tumble 9.6% Post $231 Million 1Q Loss,..
25/04/202415:00BWQ1 2024 results
16/04/202420:00BWIMFINZI® (durvalumab) plus chemotherapy doubled overall..
12/04/202420:05IHMARKETNEWSParamount Global Board Shrinks, Morgan Stanley Faces..
11/04/202420:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
11/04/202420:00BWFASENRA approved for treatment of children aged 6 to 11 with..
06/04/202412:10BWENHERTU® Approved in the U.S. as First Tumor Agnostic HER2..
06/04/202410:43BWENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the..
05/04/202420:00BWIMFINZI® (durvalumab) significantly improved overall..
02/04/202420:00BWDatopotamab deruxtecan Biologics License Application..
02/04/202415:00BWDatopotamab Deruxtecan Biologics License Application..
01/04/202420:00BWVOYDEYA™ approved in the US as add-on therapy to ravulizumab..
27/03/202419:54IHMARKETNEWSGameStop Shares Tumble 20% in Pre-Market Trading Amid..
26/03/202420:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25/03/202420:00BWULTOMIRIS® (ravulizumab-cwvz) approved in the US for the..
19/03/202420:33IHMARKETNEWSUnilever Initiates Ice Cream Division Spin-Off and Announces..
19/03/202420:00BWAstraZeneca to acquire Fusion to accelerate the development..
19/03/202419:52IHMARKETNEWSAstraZeneca to acquire Fusion for $2 billion
18/03/202420:00BWAstraZeneca caps patient out-of-pocket costs at $35 per..
14/03/202420:39IHMARKETNEWSFisker’s Shares Take a Hit Amid Speculation of Bankruptcy,..
13/03/202420:06BWAstraZeneca announces initiation of THARROS – a Phase III..
07/03/202419:43IHMARKETNEWSTesla Exits Market Top 10, Victoria’s Secret Stock Tumbles..
27/02/202406:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/02/202423:00PRNCAAlexion Canada donne de la couleur aux maladies rares avec..
26/02/202420:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/02/202406:09EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
24/02/202403:23BWMANDARA Phase III data published in New England Journal of..
22/02/202423:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/02/202423:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/02/202421:10BWDatopotamab deruxtecan Biologics License Application..
19/02/202421:05BWTAGRISSO® (osimertinib) demonstrated overwhelming efficacy..
19/02/202416:00BWDatopotamab Deruxtecan Biologics License Application..
17/02/202412:00BWTAGRISSO® (osimertinib) with the addition of chemotherapy..
09/02/202419:51IHMARKETNEWSCloudflare Skyrockets 26% Pre-Market; Expedia Plunges 14%..
08/02/202420:10IHMARKETNEWSArm Achieves Record Revenue, PayPal Shares Plummet by More..
08/02/202416:03BWAstraZeneca Full year and Q4 2023 Financial Results
07/02/202421:31PRNUSSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing..
07/02/202420:51PRNUSSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing..
06/02/202423:00BWAstraZeneca expands US manufacturing footprint to accelerate..
05/02/202423:00GLOBEYiviva Announces Memorandum of Understanding with..
29/01/202421:00BWENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority..
25/01/202407:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/01/202421:00BWAIRSUPRA® (albuterol/budesonide) now available as the first..
20/01/202400:05BWIMFINZI® (durvalumab) plus transarterial chemoembolization..
19/01/202422:46EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
19/01/202422:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/01/202420:15IHMARKETNEWSWall Street Highlights: Apple Cuts iPhone Prices in China,..
08/01/202422:45IHNWExciting New Cures Possible from GLP-1 Diabetes, Weight-Loss..

최근 히스토리

NASDAQ
AZN
AstraZeneca
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유